Continue Reading
Full article on Bloomberg
Quest Diagnostics CEO: Chronic Care Disease Management a Big Driver
Market Intelligence Analysis
AI-Powered
Why This Matters
Quest Diagnostics CEO Jim Davis highlights chronic disease management and consumer health testing as key drivers of growth in the lab testing industry, with cancer testing being a significant contributor to the company's $11 billion portfolio.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on “The Close” that cancer testing accounts for about $1 billion of the company’s $11 billion portfolio. (Source: Bloomberg)
Original article published by
Bloomberg
on February 11, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.